Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences (warrants: OACCW) is a blank-check company sponsored by Oaktree Capital Management, the Los Angeles-based alternative investment firm, and is focused on identifying a merger target within the life sciences sector. The company filed a Form 10-Q with the SEC on November 13, 2025, under accession number 0001193125-25-280296, indicating it remains an active reporting company still in the SPAC search phase. Oaktree has operated multiple acquisition vehicles, with this third iteration reflecting continued sponsor interest in the healthcare and life sciences space. Visit SpacDesk and sign up for full data, filings history, and deal-tracking on Oaktree Acquisition Corp. III and hundreds of other active SPACs.